NCT03313531 - Evaluation of a Standardized Protocol for Thrombin Generation Assay | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 15, 2017

Primary Completion Date

January 28, 2019

Study Completion Date

January 28, 2019

Conditions

Hemophilia A

Interventions

DIAGNOSTIC_TEST

Thrombin Generation Assay

Inter lab variation and level of agreement will be determined

DRUG

Treatment with recombinant coagulation factor

To obtain a wide range of thrombingeneration levels, one person (Treated HA person) will recieve one injection of Advate and one injection of Adynovate respectively

Trial Locations (1)

20502

Coagulation Unit, department of translational medicine, Malmo